Scientific News

Cholesterol-lowering drugs could influence the gut microbiota in obese people

Obese people have a gut microbiota that is associated with inflammation. But those who take statins have a healthier gut microbiota, a new study (Nature) found.

AGA release new guidelines for taking probiotics

The American Gastroenterological Association (AGA) evaluated available evidence on clinical efficacy of probiotics for most digestive conditions.

Drug halts C. difficile infection, promotes recovery of the microbiota after antibiotic treatment

Ebselen may protect from C. difficile-associated tissue damage and bolster recovery of the microbiota after antibiotic treatment.

Gut microbiota could inhibit the growth of antibiotic-resistant bacteria

A new study shows that interactions with the resident gut microbiota could suppress the proliferation and antibiotic-resistance evolution of superbugs.

How gut bacteria contribute to the development of colorectal cancer

A new study supports the idea that the gut microbiota composition can vary in abundance and function during the development of colorectal cancer.

The path towards microbiota-based therapies

In a commentary published in Cell, five experts discuss the challenges and opportunities of microbiota-based therapies.

Underfeeding and antibiotics alter the gut microbiota and impair nutrient absorption

A new study, published in Nature Medicine, suggests that changes to the microbial community in the gut could influence nutrient metabolism.

Microbes development from old world monkey to human might have influenced social behavior and evolutionary community trends

Researchers at North Carolina State University have underlined the evolutionary interplay between microbiomes development and human social structures.

Gut microbiota composition could predict cancer treatment outcomes

According to a new study published in the journal Microbiome, cancer treatment outcomes can be modulated by the levels of specific gut bacteria.

“There is a strong relationship between gut dysbiosis, metabolic diseases and cancer”

Rémy Burcelin explains how understanding the link between gut microbiota, metabolic syndrome and cancer could be useful from a therapeutic point of view.

Intestinal bacterial burden is controlled in the fetus during human gestation

A new study shows that viable bacteria are highly limited in utero, although have capacity to limit inflammatory potential of fetal intestinal T cells.

Breastfeeding may reduce the number of harmful viruses in the infant gut

A new study shows that breast milk can be protective against viral infections by reducing the accumulation of potentially harmful human viruses.

Vaginal microbes may help to identify women at risk for cervical cancer

Researchers have identified potential microbial markers that could identify women with HPV infection at risk for progression to cervical cancer.

Malnutrition prevents immune molecules from recognizing beneficial gut bacteria

A study, published in Cell Host & Microbe, suggests why undernourished people may be more susceptible to intestinal infections than healthy individuals.

Gut microbes could protect against liver damage

A study published in Cell Metabolism shows that the gut microbiota can act at a distance to protect against liver damage.

Newly identified microbiota-derived molecules could inhibit brain function

Researchers have identified new bacterial molecules that are able to travel to the brain and inhibit brain cell function.

Fewer antibiotics linked to reduced childhood asthma

A new study (The Lancet Respiratory Medicine) suggests that the decrease in the incidence of childhood asthma is a consequence of reduced antibiotic use.

Microbiota DNA in the blood could be used to diagnose cancer

Cancer-associated microbial signatures in the blood could help to detect the disease at its early stage, a study published in Nature has found.

Mouth microbiota composition could predict the outcome of stem cell transplants

A study published in PLOS Pathogens suggests that the oral microbiota could be used to predict the outcome of hematopoietic stem cell transplants.

Newly discovered microbiota-derived compound could drive heart disease

Researchers have identified a microbial metabolite linked to events such as heart attack and stroke. The findings could lead to new ways to diagnose, prevent, and treat heart disease.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top